New hope for hepatitis b patients when standard drugs fail
Disease control
Recruiting now
This large Phase 3 trial is testing whether adding a new drug called Neracorvir (GST-HG141) helps patients with chronic hepatitis B who still have detectable virus despite taking standard antiviral pills. The study will enroll over 500 adults who haven't responded well to their c…
Phase: PHASE3 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC